Zdrowie i gospodarka · 30/11/2017
FDA to Hold Public Hearing on Nicotine Replacement Therapy Evaluation Approach
The Food and Drug Administration is seeking public input on its method for assessing the safety and effectiveness of nicotine replacement therapy products, including their intended use and labeling.
Source: Federal Register — Food and Drug AdministrationOpen original release →